Autopsy report · NCT05600426
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
Cause of deathFunding or business
“Funding terminated”
Life of this trial
- Registered 3 months before it started.
- Ran for about 3 years 6 months before it stopped.
- 53 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Boston Children's Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Severe Aplastic Anemia
- Interventions
- cyclosporine; Matched Unrelated Donor Hematopoetic Stem Cell Transplant; horse anti-thymocyte globulin (ATG); rabbit anti-thymocyte globulin (ATG); Methotrexate; Fludarabine
- Participants
- 53
- Sites
- 52
- Countries
- Canada, United States
Trials that died the same way
- The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
“Funding was terminated” - Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
“Funding terminated by funding source.” - Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
“Souces of funding have been terminated” - Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
“Terminated due to insufficient funding” - Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
“Terminated due to loss of funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.